University Hospital Ghent
Ghent, Eastern-Flanders, 9000, Belgium
NCT Number: NCT04746378
This study is intended to be a prospective registry of patients undergoing any kind of stone treatment that have a pre-operative CT available. This imaging will be used to measure the stone burden in three different ways: in a single dimension (cumulative stone diameter), in two dimensions (surface area) and in three dimensions (volume).The primary purpose is to identify what way of measuring stone burden is most predictive of outcomes after stone treatment such as stone free status, operative time and complications.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Ghent, Eastern-Flanders, 9000, Belgium
The current EAU and AUA guidelines still base the recommendations for stone treatment on cumulative stone diameter, a linear measurement of the stone burden. Multiple nomograms rather use the stone burden's surface area to predict post-operative outcomes. More recently, volume has been prposed as the most accurate measure of stone burden and the variable to be reported in stone treatment literature. Although inuitively a three dimensional evaluation is most likely the most accurate representation of the stone burden to be treated.
Several reports however have compared different ways of measuring stone burden and could not confidently identify volume as the most accurate predictor of surgical outcomes.
With this study, we aim to prospectively collect data on a large group of patients that have a pre-operative CT scan available. This imaging will be used to assess the stone burden in different ways, linear, two dimensional and three dimensional. Both procedural and post-operative data will be collected to identify which of the measurements is most accurate in predicting outcomes such as stone free status, operative time and complications such as bleeding. Patients can be included regardless of the procedure that is proposed to treat the stone. After inclusion and after having undergone the procedure, at least one post-operative assessment is necessary to be able to evaluate the pre-operative variables against post-operative outcomes.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Measurement of the stone burden by cumulative stone diameter, the sum of linear longest diameters of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other names: Cumulative Stone Diameter
Measurement of the stone burden by surface area, the sum of surface areas of all the stones to be treated within one patient as measured on the CT or by additional rendering software
Other names: Stone Surface Area
Measurement of the stone burden by volume of all the stones to be treated within one patient, as measured on the CT or by additional rendering software
Other names: Stone Volume
Time frame: 1 day to 3 months
Any residual stone fragments after the initial treatment
Time frame: intra-operative
Time needed to treat the stone burden as measured during one treatment session
Time frame: 30 days
Any complication thet can be attributed to the procedure that was performed
University Hospital, Ghent
Other
Comparison of Predictive Value of Different Stone Burden Measurements for Outcomes After Urinary Stone Treatment.
Acronym: PRAISE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07712861
Calculi, Female Urogenital Diseases
Buenos Aires, Argentina
View Trial DetailsNCT02214836
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial DetailsNCT07678255
Calculi, Female Urogenital Diseases
Seville, Spain
View Trial DetailsNCT02028559
Calculi, Female Urogenital Diseases
Seattle, Washington, United States
View Trial Details